| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.06 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |